Terapet
Latest round
- Grant
Last raised
- Oct 2026
Total raised
- $4.7M
Investors
- 6
About Terapet
Founded in 2019, Terapet SA, headquartered in Geneva, Switzerland, specializes in advanced imaging technologies for nuclear medicine. The company's founders, Christina Vallgren and Marcus Palm, have directed their efforts towards enhancing quality control in proton therapy.Terapet SA specializes in advanced imaging technologies for nuclear medicine, focusing primarily on two flagship products: Qualyscan™ and Nuclyscan™. Qualyscan™ enhances quality control in proton therapy by integrating next-generation imaging capabilities to improve diagnosis and treatment processes in radiotherapy. Nuclyscan™ complements this offering by contributing to advancements in nuclear imaging.Terapet SA generates revenue through direct sales of its imaging solutions, emphasizing B2B transactions within the healthcare industry. The company engages in partnerships with hospitals and radiotherapy clinics, providing advanced technology essential for quality control and imaging in nuclear medicine. Revenue streams consist of one-time purchases of equipment like Qualyscan™ and Nuclyscan™, as well as potential service agreements for ongoing support and maintenance. The company plans to expand its presence into new international markets, focusing on regions with high demand for advanced imaging technologies.
Who invested in Terapet
6 investors across 2 rounds
See all investors in Terapet
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Terapet
Who invested in Terapet?
Terapet has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Terapet raised?
Terapet has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Terapet last raise money?
Terapet's most recent round on record is a Grant, in Oct 2026.
What does Terapet do?
Founded in 2019, Terapet SA, headquartered in Geneva, Switzerland, specializes in advanced imaging technologies for nuclear medicine.
Where is Terapet headquartered?
Terapet is headquartered in Geneva, Switzerland.
Which VCs invest in companies like Terapet?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Terapet's stage. Their profiles are linked below.
VCs backing biotechnology startups at Grant
Raising like Terapet? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.